Abstract

Risk and Severity of Cytokine Release Syndrome in Patients with Relapsed/Refractory (R/R) AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Initial Clinical Activity and Safety of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma
Simon J Harrison ... Suzanne Trudel
Blood | VOL. 136
Simon J Harrison, et. al.Simon J Harrison ... Suzanne Trudel
05 Nov 2020
Glofitamab Step-up Dosing Induces High Response Rates in Patients (pts) with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL), Most of Whom Had Failed Prior Bruton's Tyrosine Kinase Inhibitor (BTKi) Therapy
James Relf ... Linda Lundberg
Blood | VOL. 138
James Relf, et. al.James Relf ... Linda Lundberg
05 Nov 2021
Improvement in Cytokine Release Syndrome Management for the Treatment of AML Patients with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy
Norbert Vey ... Kathy Tran
Blood | VOL. 134
Norbert Vey, et. al.Norbert Vey ... Kathy Tran
13 Nov 2019
A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM)
Sikander Ailawadhi ... Marc S Raab
Blood | VOL. 136
Sikander Ailawadhi, et. al.Sikander Ailawadhi ... Marc S Raab
05 Nov 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib.
Jennifer A Woyach ... Veerendra Munugalavadla
Blood | VOL. -
Jennifer A Woyach, et. al.Jennifer A Woyach ... Veerendra Munugalavadla
16 May 2024
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Chiara Malinverni ... Carlo Visco
Blood | VOL. -
Chiara Malinverni, et. al.Chiara Malinverni ... Carlo Visco
16 May 2024
How I manage pregnant patients who are alloimmunized to RBC antigens.
Helen Frances Savoia ... Stefan Charles Kane
Blood | VOL. -
Helen Frances Savoia, et. al.Helen Frances Savoia ... Stefan Charles Kane
14 May 2024
Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
Ross S Firestone ... David J Chung
Blood | VOL. -
Ross S Firestone, et. al.Ross S Firestone ... David J Chung
10 May 2024
View more papers